Producto añadido correctamente al carrito.

discount label
5Hexynoic-CTTHWGFTLC-OH
Ver en 3D

Biosynth logo

5Hexynoic-CTTHWGFTLC-OH

Ref. 3D-PP47215

Tamaño no definidoA consultar
Entrega estimada en Estados Unidos, el Martes 5 de Noviembre de 2024

Información del producto

Nombre:
5Hexynoic-CTTHWGFTLC-OH
Descripción:

Peptide 5Hexynoic-CTTHWGFTLC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 5Hexynoic-CTTHWGFTLC-OH include the following: Sustained release of a peptide-based matrix metalloproteinase-2 inhibitor to attenuate adverse cardiac remodeling and improve cardiac function following myocardial Z Fan , M Fu, Z Xu, B Zhang, Z Li, H Li , X Zhou - , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biomac.7b00760 Tumor homing peptides as fusion partners of therapeutic proteins for efficient delivery to cancer cells YE Lee, BH Hwang - Biotechnology and Bioprocess Engineering, 2023 - Springerhttps://link.springer.com/article/10.1007/s12257-022-0139-0 Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor Y Zou, Y Chen, Y Jiang, J Gao, J Gu - Cancer research, 2007 - AACRhttps://aacrjournals.org/cancerres/article-abstract/67/15/7295/533413 A synthetic peptide inhibits human ovarian cancer cell motility Y Wei , D Huang , K Wang, J Du, Y Hu - RSC advances, 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/ra/c5ra08755d Development of brain targeting peptide based MMP-9 inhibiting nanoparticles for the treatment of brain diseases with elevated MMP-9 activity Y Islam, A Khalid, S Pluchino , M Sivakumaran - Journal of , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354920303543 Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide W Wang, R Shao, Q Wu, S Ke, J McMurray - Molecular imaging and , 2009 - Springerhttps://link.springer.com/article/10.1007/s11307-009-0219-y THPep: a machine learning-based approach for predicting tumor homing peptides W Shoombuatong , N Schaduangrat , R Pratiwi - biology and chemistry, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1476927118309344 Systemic delivery of protein nanocages bearing CTT peptides for enhanced imaging of MMP-2 expression in metastatic tumor models T Kawano, M Murata, JS Piao, S Narahara - International journal of , 2014 - mdpi.comhttps://www.mdpi.com/1422-0067/16/1/148 A chimera of a gelatinase inhibitor peptide with streptavidin as a bifunctional tumor targeting reagent SJ Farlow, RJ Wang, MW Pandori , T Sano - FEBS letters, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014579302025656 4 Development of R de Nooijer, KM Sliedregt-Bol - Modulation of the - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2958289/download#page=80 A Phage Display Selected 7-mer Peptide Inhibitor of the Tannerella forsythia Metalloprotease-Like Enzyme Karilysin can be Truncated to Ser-Trp-Phe-Pro PD Skottrup, G Sorensen, M Ksiazek, J Potempa - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048537 Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides P Heikkila, J Suojanen, E Pirila - journal of cancer, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.21540 Binding of Novel Peptide Inhibitors of Type IV Collagenases to Phospholipid Membranes and Use in Liposome Targeting to Tumor Cells in Vitro OP Medina , T Söderlund, LJ Laakkonen - Cancer Research, 2001 - AACRhttps://aacrjournals.org/cancerres/article-abstract/61/10/3978/507449 Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide OP Medina , K Kairemo, H Valtanen - Anticancer , 2005 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/25/1A/33.short Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities MW Ndinguri, M Bhowmick , D Tokmina-Roszyk - Molecules, 2012 - mdpi.comhttps://www.mdpi.com/1420-3049/17/12/14230 Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta2 integrins M Stefanidakis, M Björklund , E Ihanus - Journal of Biological , 2003 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)83788-0/abstract Use of intein-directed peptide biosynthesis to improve serum stability and bioactivity of a gelatinase inhibitory peptide M Bjorklund , H Valtanen, H Savilahti - Chemistry & High , 2003 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cchts/2003/00000006/00000001/art00004 Vascular-homing peptides for cancer therapy L Lu, H Qi, J Zhu, WX Sun, B Zhang, CY Tang - Biomedicine & , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0753332217310879 Cy5. 5-c (Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp) NH 2 Cy5. 5-C6 K Leung - europepmc.orghttps://europepmc.org/books/n/micad/mmp-c6-cy55/ Cy5. 5-c (Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp) NH2 K Leung - 2010 - europepmc.orghttps://europepmc.org/article/nbk/nbk32323 In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models JE Sprague, WP Li, K Liang , S Achilefu - Nuclear medicine and , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0969805105002714 Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors in vivo J Suojanen, ST Vilen, P Nyberg, P Heikkila - Anticancer , 2011 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/31/11/3659.short Chemically synthesized matrix metalloproteinase and angiogenesis-inhibiting peptides as anticancer agents J Hu, M Yan, C Pu, J Wang - Anti-Cancer Agents , 2014 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/acamc/2014/00000014/00000003/art00012 Therapeutic Targeting of Angiogenesis with a Recombinant CTT Peptide-Endostatin Mimic-Kringle 5 Protein H Wang, Z Yang, J Gu - Molecular cancer therapeutics, 2014 - AACRhttps://aacrjournals.org/mct/article-abstract/13/11/2674/130808 Tumor targeting with a selective gelatinase inhibitor E Koivunen, W Arap, H Valtanen, A Rainisalo - Nature , 1999 - nature.comhttps://www.nature.com/articles/nbt0899_768 Bioconjugation of cyclometalated gold (III) lipoic acid fragments to linear and cyclic breast cancer targeting peptides D Śmià ‚owicz, JC Slootweg - Molecular , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.9b00695 Radiolabeled Matrix Metalloproteinase Inhibitors for Breast Cancer Therapy CJ Anderson , WASHINGTON UNIV ST LOUIS MO - 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/ADA410082 Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide B Kuhnast, C Bodenstein, R Haubner, HJ Wester - Nuclear medicine and , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0969805103001859 Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase A Shoari , MJ Rasaee , MR Kanavi - Journal of cellular , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.29276 Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide A Azhdarinia , N Wilganowski, H Robinson - Bioorganic & medicinal , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089611003427 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta técnica sobre: 3D-PP47215 5Hexynoic-CTTHWGFTLC-OH

Use el carrito para solicitar presupuestos o pedidos

Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".